{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:02:29Z","timestamp":1795089749138,"version":"4.10.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Gansu province","award":["Grant No.21JR1RA072"],"award-info":[{"award-number":["Grant No.21JR1RA072"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82060119"],"award-info":[{"award-number":["82060119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health Scientific Research Plan Projects of Gansu Province","award":["GSWSKY-2015-49"],"award-info":[{"award-number":["GSWSKY-2015-49"]}]},{"name":"Special Fund for Basic Scientific Research of Lanzhou University","award":["lzujbky-2021-kb37"],"award-info":[{"award-number":["lzujbky-2021-kb37"]}],"id":[{"id":"https:\/\/ror.org\/01mkqqe32","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Effective therapeutics to stop or reverse liver fibrosis have not emerged, because these potential agents cannot specifically target activated hepatic stellate cells (aHSCs) or are frequently toxic to parenchymal cells. Human umbilical cord mesenchymal stem cell (Huc-MSC)-derived exosomes show promise in nanomedicine for the treatment of liver fibrosis. However, systemic injection showed that unmodified exosomes were mainly taken up by the mononuclear phagocyte system. The discovery of ligands that selectively bind to a specific target plays a crucial role in clinically relevant diagnostics and therapeutics. Herein, we aimed to identify the targeting peptide of aHSCs by screening a phage-displayed peptide library, and modify Huc-MSC-derived exosomes with the targeting peptide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this study, we screened a phage-displayed peptide library by biopanning for peptides preferentially bound to HSC-T6 cells. The identified peptide, HSTP1, also exhibited better targeting ability to aHSCs in pathological sections of fibrotic liver tissues. Then, HSTP1 was fused with exosomal enriched membrane protein (Lamp2b) and was displayed on the surface of exosomes through genetic engineering technology. The engineered exosomes (HSTP1-Exos) could be more efficiently internalized by HSC-T6 cells and outperformed both unmodified exosomes (Blank-Exos) and Lamp2b protein overexpressed exosomes (Lamp2b\u2009+\u2009Exos) in enhancing the ability of exosomes to promote HSC-T6 reversion to a quiescent phenotype. In vivo results showed HSTP1-Exos could specifically target to the aHSC region after intravenous administration, as demonstrated by coimmunofluorescence with the typical aHSCs marker \u03b1-SMA, and enhance the therapeutic effect on liver fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These results suggest that HSTP1 is a reliable targeting peptide that can specifically bind to aHSCs and that HSTP1-modified exosomes realize the precise treatment for aHSCs in complex liver tissue. We provide a novel strategy for clinical liver fibrosis therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12951-022-01636-x","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T07:02:44Z","timestamp":1664607764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy"],"prefix":"10.1186","volume":"20","author":[{"given":"Yan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtian","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"issue":"12","key":"1636_CR1","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","volume":"18","author":"AM Moon","year":"2020","unstructured":"Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18(12):2650\u201366.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1636_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.05.056","volume":"75","author":"XS Du","year":"2019","unstructured":"Du XS, Li HD, Yang XJ, Li JJ, Xu JJ, Chen Y, Xu QQ, Yang L, He CS, Huang C, et al. Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis. Int Immunopharmacol. 2019;75: 105671.","journal-title":"Int Immunopharmacol"},{"key":"1636_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32239","author":"E Devaraj","year":"2021","unstructured":"Devaraj E, Perumal E, Subramaniyan R, Mustapha N. Liver fibrosis: extracellular vesicles mediated intercellular communication in perisinusoidal space. Hepatology. 2021. https:\/\/doi.org\/10.1002\/hep.32239.","journal-title":"Hepatology"},{"issue":"1","key":"1636_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.gastro.2020.03.008","volume":"159","author":"M Mejias","year":"2020","unstructured":"Mejias M, Gallego J, Naranjo-Suarez S, Ramirez M, Pell N, Manzano A, Su\u00f1er C, Bartrons R, Mendez R, Fernandez M. Cpeb4 increases expression of PFKFB3 to induce glycolysis and activate mouse and human hepatic stellate cells, promoting liver fibrosis. Gastroenterology. 2020;159(1):273\u201388.","journal-title":"Gastroenterology"},{"issue":"1","key":"1636_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12951-020-00645-y","volume":"18","author":"D Ji","year":"2020","unstructured":"Ji D, Wang Q, Zhao Q, Tong H, Yu M, Wang M, Lu T, Jiang C. Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy. J Nanobiotechnology. 2020;18(1):86.","journal-title":"J Nanobiotechnology"},{"issue":"6","key":"1636_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.33549\/physiolres.934755","volume":"70","author":"N Luo","year":"2021","unstructured":"Luo N, Li J, Wei Y, Lu J, Dong R. Hepatic stellate cell: a double-edged sword in the liver. Physiol Res. 2021;70(6):821\u20139.","journal-title":"Physiol Res"},{"issue":"6","key":"1636_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2020.158674","volume":"1865","author":"MW Haaker","year":"2020","unstructured":"Haaker MW, Vaandrager AB, Helms JB. Retinoids in health and disease: a role for hepatic stellate cells in affecting retinoid levels. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(6): 158674.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"23","key":"1636_CR8","doi-asserted-by":"publisher","first-page":"12782","DOI":"10.3390\/ijms222312782","volume":"22","author":"M Schinagl","year":"2021","unstructured":"Schinagl M, Tomin T, Gindlhuber J, Honeder S, Pfleger R, Schittmayer M, Trauner M, Birner-Gruenberger R. Proteomic changes of activated hepatic stellate cells. Int J Mol Sci. 2021;22(23):12782.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1636_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1053\/j.gastro.2019.05.066","volume":"157","author":"J Yan","year":"2019","unstructured":"Yan J, Tung HC, Li S, Niu Y, Garbacz WG, Lu P, Bi Y, Li Y, He J, Xu M, et al. Aryl hydrocarbon receptor signaling prevents activation of hepatic stellate cells and liver fibrogenesis in mice. Gastroenterology. 2019;157(3):793-806.e714.","journal-title":"Gastroenterology"},{"issue":"24","key":"1636_CR10","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.1073\/pnas.1201840109","volume":"109","author":"T Kisseleva","year":"2012","unstructured":"Kisseleva T, Cong M, Paik Y, Scholten D, Jiang C, Benner C, Iwaisako K, Moore-Morris T, Scott B, Tsukamoto H, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci U S A. 2012;109(24):9448\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1636_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-022-10344-w","author":"S Kannan","year":"2022","unstructured":"Kannan S, Viswanathan P, Gupta PK, Kolkundkar UK. Characteristics of pooled wharton\u2019s jelly mesenchymal stromal cells (WJ-MSCs) and their potential role in rheumatoid arthritis treatment. Stem Cell Rev Rep. 2022. https:\/\/doi.org\/10.1007\/s12015-022-10344-w.","journal-title":"Stem Cell Rev Rep"},{"key":"1636_CR12","first-page":"6685605","volume":"2021","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Gu T, Zhang Y, Li H, Zhuansun X, Xu S, Kuang Y. Human umbilical cord mesenchymal stem cells ameliorate hepatic stellate cell activation and liver fibrosis by upregulating microRNA-455-3p through suppression of p21-activated kinase-2. Biomed Res Int. 2021;2021:6685605.","journal-title":"Biomed Res Int"},{"issue":"1","key":"1636_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13287-019-1539-8","volume":"11","author":"L Dong","year":"2020","unstructured":"Dong L, Pu Y, Chen X, Qi X, Zhang L, Xu L, Li W, Ma Y, Zhou S, Zhu J, et al. hUCMSC-extracellular vesicles downregulated hepatic stellate cell activation and reduced liver injury in S. japonicum-infected mice. Stem Cell Res Ther. 2020;11(1):21.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"1636_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s13287-020-01895-1","volume":"11","author":"C Hu","year":"2020","unstructured":"Hu C, Zhao L, Zhang L, Bao Q, Li L. Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury. Stem Cell Res Ther. 2020;11(1):377.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"1636_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.63","volume":"49","author":"G Lou","year":"2017","unstructured":"Lou G, Chen Z, Zheng M, Liu Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017;49(6): e346.","journal-title":"Exp Mol Med"},{"issue":"1","key":"1636_CR16","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/s41598-022-06824-1","volume":"12","author":"JS Heo","year":"2022","unstructured":"Heo JS, Kim S. Human adipose mesenchymal stem cells modulate inflammation and angiogenesis through exosomes. Sci Rep. 2022;12(1):2776.","journal-title":"Sci Rep"},{"issue":"9","key":"1636_CR17","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/biom10091320","volume":"10","author":"R Guy","year":"2020","unstructured":"Guy R, Offen D. Promising opportunities for treating neurodegenerative diseases with mesenchymal stem cell-derived exosomes. Biomolecules. 2020;10(9):1320.","journal-title":"Biomolecules"},{"issue":"4","key":"1636_CR18","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.ymthe.2020.12.025","volume":"29","author":"J Kim","year":"2021","unstructured":"Kim J, Lee C, Shin Y, Wang S, Han J, Kim M, Kim JM, Shin SC, Lee BJ, Kim TJ, et al. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p. Mol Ther. 2021;29(4):1471\u201386.","journal-title":"Mol Ther"},{"issue":"1","key":"1636_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.7150\/thno.38198","volume":"10","author":"Z Wan","year":"2020","unstructured":"Wan Z, Zhao L, Lu F, Gao X, Dong Y, Zhao Y, Wei M, Yang G, Xing C, Liu L. Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium. Theranostics. 2020;10(1):218\u201330.","journal-title":"Theranostics"},{"key":"1636_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jare.2021.01.001","volume":"31","author":"N Parada","year":"2021","unstructured":"Parada N, Romero-Trujillo A, Georges N, Alcayaga-Miranda F. Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res. 2021;31:61\u201374.","journal-title":"J Adv Res"},{"key":"1636_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27\u201342.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1636_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00535-017-1404-4","volume":"53","author":"L Shang","year":"2018","unstructured":"Shang L, Hosseini M, Liu X, Kisseleva T, Brenner DA. Human hepatic stellate cell isolation and characterization. J Gastroenterol. 2018;53(1):6\u201317.","journal-title":"J Gastroenterol"},{"issue":"6","key":"1636_CR23","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/hep.31215","volume":"72","author":"MK Terkelsen","year":"2020","unstructured":"Terkelsen MK, Bendixen SM, Hansen D, Scott EAH, Moeller AF, Nielsen R, Mandrup S, Schlosser A, Andersen TL, Sorensen GL, et al. Transcriptional dynamics of hepatic sinusoid-associated cells after liver injury. Hepatology. 2020;72(6):2119\u201333.","journal-title":"Hepatology"},{"issue":"2","key":"1636_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/1061186X.2019.1641508","volume":"28","author":"Y Lin","year":"2020","unstructured":"Lin Y, Lu Y, Li X. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents. J Drug Target. 2020;28(2):129\u201341.","journal-title":"J Drug Target"},{"key":"1636_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120539","volume":"269","author":"X Xu","year":"2021","unstructured":"Xu X, Liang Y, Li X, Ouyang K, Wang M, Cao T, Li W, Liu J, Xiong J, Li B, et al. Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration. Biomaterials. 2021;269: 120539.","journal-title":"Biomaterials"},{"issue":"3","key":"1636_CR26","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/hep.31418","volume":"73","author":"J Zhang","year":"2021","unstructured":"Zhang J, Li Y, Liu Q, Huang Y, Li R, Wu T, Zhang Z, Zhou J, Huang H, Tang Q, et al. Sirt6 alleviated liver fibrosis by deacetylating conserved lysine 54 on smad2 in hepatic stellate cells. Hepatology. 2021;73(3):1140\u201357.","journal-title":"Hepatology"},{"issue":"5","key":"1636_CR27","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1002\/hep.31987","volume":"74","author":"W Yang","year":"2021","unstructured":"Yang W, He H, Wang T, Su N, Zhang F, Jiang K, Zhu J, Zhang C, Niu K, Wang L, et al. Single-cell transcriptomic analysis reveals a hepatic stellate cell-activation roadmap and myofibroblast origin during liver fibrosis in mice. Hepatology. 2021;74(5):2774\u201390.","journal-title":"Hepatology"},{"key":"1636_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119984","volume":"247","author":"S Gurung","year":"2020","unstructured":"Gurung S, Khan F, Gunassekaran GR, Yoo JD, Poongkavithai Vadevoo SM, Permpoon U, Kim SH, Kim HJ, Kim IS, Han H, et al. Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression. Biomaterials. 2020;247: 119984.","journal-title":"Biomaterials"},{"issue":"11","key":"1636_CR29","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s13238-019-0639-7","volume":"10","author":"PE Saw","year":"2019","unstructured":"Saw PE, Song EW. Phage display screening of therapeutic peptide for cancer targeting and therapy. Protein Cell. 2019;10(11):787\u2013807.","journal-title":"Protein Cell"},{"issue":"15","key":"1636_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008737","volume":"7","author":"X Wang","year":"2018","unstructured":"Wang X, Chen Y, Zhao Z, Meng Q, Yu Y, Sun J, Yang Z, Chen Y, Li J, Ma T, et al. Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction. J Am Heart Assoc. 2018;7(15): e008737.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"1636_CR31","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00726-016-2329-6","volume":"48","author":"B Bakhshinejad","year":"2016","unstructured":"Bakhshinejad B, Zade HM, Shekarabi HS, Neman S. Phage display biopanning and isolation of target-unrelated peptides: in search of nonspecific binders hidden in a combinatorial library. Amino Acids. 2016;48(12):2699\u2013716.","journal-title":"Amino Acids"},{"issue":"1","key":"1636_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-019-1512-5","volume":"39","author":"G Lou","year":"2020","unstructured":"Lou G, Chen L, Xia C, Wang W, Qi J, Li A, Zhao L, Chen Z, Zheng M, Liu Y. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway. J Exp Clin Cancer Res. 2020;39(1):4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1636_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12951-022-01352-6","volume":"20","author":"J Chen","year":"2022","unstructured":"Chen J, Huang T, Liu R, Wang C, Jiang H, Sun H. Congenital microtia patients: the genetically engineered exosomes released from porous gelatin methacryloyl hydrogel for downstream small RNA profiling, functional modulation of microtia chondrocytes and tissue-engineered ear cartilage regeneration. J Nanobiotechnology. 2022;20(1):164.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"1636_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13287-019-1204-2","volume":"10","author":"X Rong","year":"2019","unstructured":"Rong X, Liu J, Yao X, Jiang T, Wang Y, Xie F. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt\/\u03b2-catenin pathway. Stem Cell Res Ther. 2019;10(1):98.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"1636_CR35","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, Wang M, Zhou Y, Zhu W, Li W, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22(6):845\u201354.","journal-title":"Stem Cells Dev"},{"key":"1636_CR36","doi-asserted-by":"publisher","first-page":"14135","DOI":"10.1038\/srep14135","volume":"5","author":"J Hyun","year":"2015","unstructured":"Hyun J, Wang S, Kim J, Kim GJ, Jung Y. MicroRNA125b-mediated Hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells. Sci Rep. 2015;5:14135.","journal-title":"Sci Rep"},{"key":"1636_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.biomaterials.2017.10.012","volume":"150","author":"T Tian","year":"2018","unstructured":"Tian T, Zhang HX, He CP, Fan S, Zhu YL, Qi C, Huang NP, Xiao ZD, Lu ZH, Tannous BA, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137\u201349.","journal-title":"Biomaterials"},{"issue":"5","key":"1636_CR38","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","volume":"154","author":"K Du","year":"2018","unstructured":"Du K, Hyun J, Premont RT, Choi SS, Michelotti GA, Swiderska-Syn M, Dalton GD, Thelen E, Rizi BS, Jung Y, et al. Hedgehog-YAP signaling pathway regulates glutaminolysis to control activation of hepatic stellate cells. Gastroenterology. 2018;154(5):1465-1479.e1413.","journal-title":"Gastroenterology"},{"key":"1636_CR39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.biopha.2018.02.091","volume":"101","author":"L Qin","year":"2018","unstructured":"Qin L, Qin J, Zhen X, Yang Q, Huang L. Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12\/CXCR4 biological axis in liver fibrosis: a study in vitro and in vivo. Biomed Pharmacother. 2018;101:599\u2013607.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1636_CR40","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/hep.30965","volume":"71","author":"Y Nakano","year":"2020","unstructured":"Nakano Y, Kamiya A, Sumiyoshi H, Tsuruya K, Kagawa T, Inagaki Y. A Deactivation factor of fibrogenic hepatic stellate cells induces regression of liver fibrosis in mice. Hepatology. 2020;71(4):1437\u201352.","journal-title":"Hepatology"},{"key":"1636_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.801340","volume":"12","author":"EM Mastoridou","year":"2021","unstructured":"Mastoridou EM, Goussia AC, Glantzounis GK, Kanavaros P, Charchanti AV. Autophagy and exosomes: cross-regulated pathways playing major roles in hepatic stellate cells activation and liver fibrosis. Front Physiol. 2021;12: 801340.","journal-title":"Front Physiol"},{"issue":"8","key":"1636_CR42","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/1061186X.2017.1322598","volume":"25","author":"Z Guo","year":"2017","unstructured":"Guo Z, Li D, Peng H, Kang J, Jiang X, Xie X, Sun D, Jiang H. Specific hepatic stellate cell-penetrating peptide targeted delivery of a KLA peptide reduces collagen accumulation by inducing apoptosis. J Drug Target. 2017;25(8):715\u201323.","journal-title":"J Drug Target"},{"key":"1636_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jconrel.2018.05.032","volume":"283","author":"JB Qiao","year":"2018","unstructured":"Qiao JB, Fan QQ, Xing L, Cui PF, He YJ, Zhu JC, Wang L, Pang T, Oh YK, Zhang C, et al. Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis. J Control Release. 2018;283:113\u201325.","journal-title":"J Control Release"},{"issue":"1","key":"1636_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41551-019-0485-1","volume":"4","author":"Z Yang","year":"2020","unstructured":"Yang Z, Shi J, Xie J, Wang Y, Sun J, Liu T, Zhao Y, Zhao X, Wang X, Ma Y, et al. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat Biomed Eng. 2020;4(1):69\u201383.","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"1636_CR45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12951-021-01010-3","volume":"19","author":"M Jeon","year":"2021","unstructured":"Jeon M, Kim G, Lee W, Baek S, Jung HN, Im HJ. Development of theranostic dual-layered Au-liposome for effective tumor targeting and photothermal therapy. J Nanobiotechnology. 2021;19(1):262.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"1636_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12951-020-00684-5","volume":"18","author":"J Choi","year":"2020","unstructured":"Choi J, Kim G, Cho SB, Im HJ. Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme. J Nanobiotechnology. 2020;18(1):122.","journal-title":"J Nanobiotechnology"},{"issue":"4","key":"1636_CR47","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2017.05.022","volume":"67","author":"PF Ma","year":"2017","unstructured":"Ma PF, Gao CC, Yi J, Zhao JL, Liang SQ, Zhao Y, Ye YC, Bai J, Zheng QJ, Dou KF, et al. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice. J Hepatol. 2017;67(4):770\u20139.","journal-title":"J Hepatol"},{"key":"1636_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.627927","volume":"8","author":"S Xi","year":"2021","unstructured":"Xi S, Zheng X, Li X, Jiang Y, Wu Y, Gong J, Jie Y, Li Z, Cao J, Sha L, et al. Activated hepatic stellate cells induce infiltration and formation of CD163(+) macrophages via CCL2\/CCR2 pathway. Front Med (Lausanne). 2021;8: 627927.","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"1636_CR49","first-page":"927","volume":"19","author":"D Sahin","year":"2018","unstructured":"Sahin D, Taflan SO, Yartas G, Ashktorab H, Smoot DT. Screening and identification of peptides specifically targeted to gastric cancer cells from a phage display peptide library. Asian Pac J Cancer Prev. 2018;19(4):927\u201332.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1636_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2021.11.015","volume":"526","author":"F Zhang","year":"2022","unstructured":"Zhang F, Guo J, Zhang Z, Qian Y, Wang G, Duan M, Zhao H, Yang Z, Jiang X. Mesenchymal stem cell-derived exosome: a tumor regulator and carrier for targeted tumor therapy. Cancer Lett. 2022;526:29\u201340.","journal-title":"Cancer Lett"},{"key":"1636_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.04.034","volume":"134","author":"H Ramaraju","year":"2017","unstructured":"Ramaraju H, Miller SJ, Kohn DH. Dual-functioning peptides discovered by phage display increase the magnitude and specificity of BMSC attachment to mineralized biomaterials. Biomaterials. 2017;134:1\u201312.","journal-title":"Biomaterials"},{"issue":"1","key":"1636_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12951-019-0461-7","volume":"17","author":"H Zhang","year":"2019","unstructured":"Zhang H, Wu J, Wu J, Fan Q, Zhou J, Wu J, Liu S, Zang J, Ye J, Xiao M, et al. Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice. J Nanobiotechnology. 2019;17(1):29.","journal-title":"J Nanobiotechnology"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01636-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01636-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01636-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T08:03:43Z","timestamp":1664611423000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01636-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1636"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01636-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]},"assertion":[{"value":"7 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the First Hospital of Lanzhou University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"432"}}